Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-06-26 02:02 UTC

BIOMED PULSE

Daily Briefing on Longevity, Viruses, and New Cures

Thursday, June 26, 2026

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in DRC and Uganda has now reached 896 confirmed cases and 232 deaths as of June 17, making it the dominant global health emergency of the moment. [1]

Mood: Urgent on filovirus and Nipah fronts, watchful on hantavirus, mixed on longevity science.

🦠 OUTBREAKS & VIRUSES

EBOLA BUNDIBUGYO VIRUS - DRC AND UGANDA (ACTIVE PHEIC)

  • As of June 17, 2026, WHO confirmed 896 cumulative cases and 232 deaths from Bundibugyo virus disease (BVD) in DRC, with sustained cross-border transmission to Uganda. [1]
  • WHO declared BVD a Public Health Emergency of International Concern on May 16-17, 2026; the IHR Emergency Committee confirmed it does not yet meet criteria for a full pandemic emergency. [2][3]
  • Africa CDC and WHO launched a joint continental preparedness and response plan on June 5, 2026, seeking to raise US$ 518 million to support African countries in the response. [4]
  • WHO issued its first comprehensive clinical management guidelines covering all filovirus types, including all Ebola strains and Marburg, on June 17, 2026, directly in response to the BVD outbreak. [5]
  • CDC mobilized an international Ebola response starting May 17, 2026, and expanded enhanced airport screening from Washington-Dulles to Atlanta by May 23, 2026. [6][7][8]
  • WHO expert groups convened May 28, 2026 assessed candidate vaccines and therapeutics specific to Bundibugyo virus; no licensed product currently exists for this strain. [9]

NIPAH VIRUS - INDIA (NEW, JUNE 2026)

  • On June 11, 2026, Kerala State Health Department confirmed one laboratory-confirmed Nipah virus (NiV) case in Kozhikode district; the adult male developed neurological symptoms on May 30 and was hospitalized June 10. [10]
  • This follows earlier 2026 NiV detections: two healthcare workers in West Bengal, India (confirmed January 26) and one case in Rajshahi Division, Bangladesh (confirmed February 3).

HANTAVIRUS - M/V HONDIUS CRUISE SHIP (ONGOING)

  • CDC issued a Hantavirus response update on June 24, 2026; the outbreak of Andes hantavirus linked to the M/V Hondius cruise ship has involved multiple countries since first reported to WHO on May 2, 2026.
  • WHO's fourth Disease Outbreak News report (May 28) confirmed the pathogen as Andes hantavirus, with passengers from 23 countries affected; over 120 passengers were safely disembarked from Tenerife.
  • As of mid-May, confirmed cases had grown beyond the initial seven cases (two lab-confirmed, five suspected) reported in early May.

YELLOW FEVER - GLOBAL

  • WHO reported that from January 1 to May 26, 2026, six countries reported a total of 79 human yellow fever infections; transmission activity in the Americas that surged in 2025 has carried into 2026.

MEASLES - BANGLADESH AND GLOBAL

  • WHO notified of a nationwide measles surge in Bangladesh as of April 4, 2026, with 19,161 suspected cases and 2,897 laboratory-confirmed cases affecting 58 of 64 districts across all eight divisions.
  • Globally, measles infected 10.3 million people in 2023, a figure reported by CDC in November 2024.

CDC ACIP MEETING - JUNE 25-26, 2025 (VACCINE POLICY NOTE)

  • CDC's Advisory Committee on Immunization Practices concluded its June 25-26, 2025 meeting and issued a joint statement; agenda covered data on multiple vaccines.

MPOX - RECOMBINANT STRAIN

  • WHO reported in February 2026 two cases of a recombinant MPXV strain carrying genomic elements of both clade Ib and clade IIb, a known but concerning natural recombination event when two strains co-infect one individual.

SALMONELLA - MULTIPLE ACTIVE OUTBREAKS

  • CDC warned of ongoing Salmonella outbreaks linked to backyard poultry (34 people, 13 states, April 2026; updated May 2026 to 150+ additional people, over one-quarter under age 5).
  • CDC also flagged separate Salmonella outbreaks linked to pistachio cream (4 cases, June 16), whole cucumbers (May 20), and eggs (June 7).

LISTERIA - CHICKEN FETTUCCINE ALFREDO

  • CDC warned on June 19, 2026 of a Listeria outbreak linked to recalled chicken fettuccine alfredo meals, with 17 people sick from the same strain.

DRUG-RESISTANT BACTERIA

  • A CDC report released September 23, 2025 found a dramatic rise in dangerous drug-resistant bacteria, underscoring the broader antimicrobial resistance threat.

🧬 LONGEVITY & AGING

SENESCENCE AND KIDNEY REPAIR

  • A study in Ren Fail (June 14, 2026) found that AMD1-mediated polyamine metabolism governs whether kidney tubular cells repair or enter senescence after injury, identifying a potential target to reduce age-related organ decline.

DNA METHYLATION, TELOMERES, AND BRAIN ANEURYSM RISK

  • A genetic study in IBRO Neuroscience Reports (May 30, 2026) used Mendelian randomization to link DNA methylation-estimated aging phenotypes and shorter telomere length to elevated risk of intracranial aneurysms, connecting epigenetic aging clocks to vascular risk.

CHONDROCYTE SENESCENCE AND A NINE-GENE DECLINE MODULE

  • Research in Regenerative Therapy (June 13, 2026) on long-term expandable auricular chondrocytes identified a conserved nine-gene module that drives dedifferentiation independently of classic senescence pathways, relevant to cartilage aging and tissue engineering.

HYPERTENSION AND FRAILTY IN OLDER ADULTS

  • A longitudinal study from India published in Blood Press (June 21, 2026) found significant associations between hypertension and frailty among middle-aged and older adults, using data from the Longitudinal Ageing Study in India.

HANDGRIP STRENGTH AND DIGESTIVE DISEASE

  • A prospective study in Global Health Action (June 15, 2026) across Chinese and European older adult cohorts found that lower combined handgrip strength was independently associated with higher incidence of chronic digestive diseases, suggesting grip strength as a useful aging biomarker.

MULTIPLE LONG-TERM CONDITIONS AND KIDNEY DISEASE MORTALITY

  • The NURTuRE-CKD multicentre cohort study (Ann Med, June 23, 2026) found that having multiple long-term conditions significantly worsens mortality, progression to kidney failure, and health-related quality of life in people with chronic kidney disease.

MATERNAL DIET, NEONATAL MICROBIOME, AND NEUROMETABOLIC RESILIENCE

  • Research in Gut Microbes (June 9, 2026) by Kadyan et al. showed that maternal diet shapes the neonatal microbiome's early developmental trajectory and influences neurometabolic resilience, linking prenatal nutrition to offspring brain-metabolic health.

GUT MICROBIOME AND CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME

  • A Gut Microbes review (June 15, 2026) by Xu, Snelson, and Marques analyzed how gut-derived uremic toxins produced by the microbiome drive cardiovascular-kidney-metabolic syndrome, a cluster of age-accelerating conditions.

REPRODUCTIVE AGING AND DELAYED CHILDBEARING

  • A narrative review in J Obstet Gynaecol (June 9, 2026) by Yang et al. examined how delayed childbearing interacts with reproductive aging trajectories, noting accelerating ovarian reserve decline after age 35.

ERGOTHIONEINE CO-PRODUCTION RESEARCH

  • A synthetic biology study (Synth Syst Biotechnol, June 10, 2026) engineered Saccharomyces cerevisiae to co-produce ergothioneine, salidroside, and gadusol - three compounds with antioxidant and cellular-protective properties under study for longevity-relevant pathways.

COLLAGEN OXIDATION AND AGING

  • A review in Redox Reports (June 11, 2026) by Mathias-Netto et al. detailed how both enzymatic and non-enzymatic oxidation of fibrillar collagen contribute to tissue stiffening and aging-associated extracellular matrix breakdown.

💊 NEW CURES & APPROVALS

NOTE: The openFDA items in today's data feed carry no valid approval dates ("Invalid Date") and all represent supplemental actions (SUPPL AP) on existing applications rather than new drug approvals. They are listed briefly for completeness.

OPIOID ANALGESIC SUPPLEMENTAL ACTIONS

  • Hikma received supplemental approval actions for Tapentadol Hydrochloride (ANDA205057) and Meperidine Hydrochloride (ANDA040110), both Schedule II analgesics.
  • Ascent Pharms received supplemental actions for Oxycodone and Acetaminophen (ANDA207419) and Oxycodone Hydrochloride alone (ANDA207418).
  • Granules received a supplemental action for Oxycodone and Acetaminophen (ANDA211708).
  • Kindeva received a supplemental action for Fentanyl-100 transdermal patch (ANDA202097).

JAK INHIBITOR LIQUID FORMULATION

  • AbbVie received a supplemental approval for Rinvoq LQ (upadacitinib oral liquid, NDA218347), a JAK1 inhibitor indicated for inflammatory conditions including rheumatoid arthritis and atopic dermatitis.

🧪 CLINICAL TRIALS

COGNITIVE DECLINE PREVENTION IN OLDER ADULTS - MEXICO

  • A new trial (NCT07668440, registered June 25, 2026) will test a remote, multidomain website-based intervention to prevent cognitive decline in older adults in Mexico, where dementia prevalence exceeds 8% and is projected to affect 3.5 million people by 2050.

NON-INVASIVE BRAIN STIMULATION IN PREFRAIL OLDER ADULTS

  • Trial NCT07346989 (registered June 25, 2026) evaluates transcranial neuromodulation combined with therapeutic exercise to improve neuroplasticity and functional capacity specifically in prefrail older adults, targeting a pre-disability window.

FUNCTIONAL HEALTH IN MIDLIFE WOMEN

  • Observational trial NCT07667699 (June 25, 2026) is studying multidimensional determinants of functional health - including muscle strength, bone mineral density, body composition, sleep quality, and menopausal status - in women aged 45 to 60.

NON-OPIOID ANALGESIC CANDIDATE - (2R,6R)-HNK

  • Trial NCT07504601 (June 25, 2026) at NIH is testing a single dose of (2R,6R)-hydroxynorketamine, a ketamine metabolite, for acute pain in healthy volunteers as a potential non-addictive opioid alternative, motivated by more than 14,000 annual U.S. opioid overdose deaths.

INHALED AZACYTIDINE PLUS DURVALUMAB IN EARLY-STAGE LUNG CANCER

  • Trial AZA-AEGEAN (NCT06694454, June 25, 2026) combines inhaled azacytidine (epigenetic agent) with platinum chemotherapy and durvalumab (anti-PD-L1) as neoadjuvant therapy for operable early-stage non-small cell lung cancer.

FIBROBLAST ACTIVATION PROTEIN PET IMAGING IN FIBROTIC DISEASE

  • Trial NCT07613099 (June 25, 2026) is using 18F-FAPI-74 PET/CT to detect early-stage fibrosis in heart and lung before it becomes irreversible, potentially enabling earlier intervention in age-related fibrotic diseases.

PROSTATE CANCER IMMUNOTHERAPY VACCINE ON ACTIVE SURVEILLANCE

  • Trial NCT07574541 (June 25, 2026) tests a multitargeted recombinant Ad5 PSA/MUC-1/Brachyury-based vaccine (TriAdeno) combined with IL-15 superagonist N-803 in men with low-grade localized prostate cancer on active surveillance, aiming to prevent the 35% progression rate seen within 5 years.

📢 PUBLIC HEALTH

UNSAFE FOOD KILLS 1.5 MILLION ANNUALLY - WHO

  • WHO released new estimates on June 3, 2026 showing unsafe food causes 866 million illnesses and 1.5 million deaths per year globally; children under five face nearly three times the illness risk of older individuals.

CDC ACIP JUNE 2026 OUTCOMES

  • ACIP met June 25-26, 2025 and concluded with a joint statement; CDC has in recent months shifted COVID-19 vaccination to individual-based decision-making and updated the childhood immunization schedule via a January 2026 presidential memorandum.

LISTERIA OUTBREAK - REQUESÓN/SOFT RICOTTA CHEESE

  • CDC warned on June 5, 2026 of a Listeria outbreak linked to requesón/soft ricotta cheese; consumers should avoid any implicated product.

INFANT BOTULISM - NARA ORGANICS FORMULA

  • CDC updated its infant botulism outbreak notice on June 13, 2026, urging parents to immediately stop using Nara Organics Whole Milk Organic Infant Formula linked to the outbreak.

NEW WORLD SCREWWORM - CDC EMERGENCY OPERATIONS

  • CDC activated its Emergency Operations Center for a New World Screwworm response on June 12, 2026, a parasitic fly larva (Cochliomyia hominivorax) that can infest open wounds in humans and animals.

SALMONELLA AND MORINGA SUPPLEMENTS - ONGOING MULTI-OUTBREAK ALERT

  • CDC's May 27, 2026 alert noted a growing number of Salmonella illnesses across multiple linked outbreaks tied to moringa leaf products; an extensively drug-resistant strain was flagged in a February 2026 update with three hospitalizations.

TICK BITE ER VISITS - ABOVE SEASONAL AVERAGE

  • CDC reported on April 23, 2026 that weekly emergency room visits for tick bites are higher than usual for the season, urging use of repellents and tick checks as the 2026 tick season intensifies.

WHO GLOBAL HEALTH STATUS WARNING

  • WHO's World Health Statistics 2026 report (May 13, 2026) warned that progress on global health targets is uneven, slowing, and in some areas reversing, naming it a threat of reversal for hard-won gains.

This briefing is informational only and does not constitute medical advice. Always consult qualified healthcare professionals for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda — WHO Disease Outbreak News
  2. Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a pub — WHO News
  3. First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic — WHO News
  4. Africa CDC and WHO launch joint continental Ebola response plan — WHO News
  5. WHO issues comprehensive guidelines on filovirus disease, including Ebola and Marburg disease — WHO News
  6. CDC Mobilizes International Response Following Ebola Disease Outbreak in DRC and Uganda — CDC Newsroom
  7. Enhanced Ebola Airport Screening Begins at Washington-Dulles International Airport — CDC Newsroom
  8. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  9. Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus — WHO News
  10. Nipah virus disease - India — WHO Disease Outbreak News

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260626-02-v12 · 2026-06-26 02:02 UTC

Read next